Analysis

5 Recent Fed. Circ. Rulings IP Attys Need To Know

Law360, New York (April 7, 2017, 3:39 PM EDT) -- The Federal Circuit has recently foreclosed some appeals from the Patent Trial and Appeal Board and made the America Invents Act’s covered business method review program less potent. Here's a roundup of the court’s top rulings since January and their implications for intellectual property law.

Phigenix Inc. v. ImmunoGen Inc.

While the AIA says any party dissatisfied with a Patent Trial and Appeal Board decision can appeal, the Federal Circuit held in January that appellants must still comply with the constitutional requirements for bringing a case...
To view the full article, register now.